AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home hLife Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Letter | Open Access

Ferritin-NP-preS1 vaccine synergizes with siRNA for sustained seroconversion against chronic hepatitis B in mice

Wenjun Wang1( ), Xiaoxiao Zhou2,3, Tingting Guo4, Qian Chai1, Hongjun Wang4, Mingzhao Zhu1,2,3( )
Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China
Beijing Tide Pharmaceutical Co., Ltd., Beijing, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
hLife
Volume 3 Issue 7,
July 2025
Pages 357-359
DOI: 10.1016/j.hlife.2025.02.004

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Wang W, Zhou X, Guo T, et al. Ferritin-NP-preS1 vaccine synergizes with siRNA for sustained seroconversion against chronic hepatitis B in mice. hLife, 2025, 3(7): 357-359. https://doi.org/10.1016/j.hlife.2025.02.004

504

Views

3

Crossref
Received: 19 December 2024
Revised: 06 February 2025
Accepted: 13 February 2025
Published: 01 July 2025
© 2025 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).